Full OTC Status For Two-Dose Emergency Contraceptives – Appellate Court
This article was originally published in The Tan Sheet
You may also be interested in...
In Brief
Abbott maintains diversified businesses course; citizen petition not germane to Plan B One-Step, DoJ says; Matrix noni and silver claims flagged by FDA; FDA warns e-commerce firm on claims; FDA finalizes imported food reporting rule; and Euromonitor predicts Indonesian growth spurt.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.
NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building
NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.